Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
NCT06737042
Body Weight, Body Weight Changes
Bessemer, Alabama, United States
View Trial DetailsNCT Number: NCT01889225
Previous analyses of the National Health and Nutrition Examination Survey have suggested that the mortality rate associated with obesity has decreased over calendar time in the U.S. population, potentially due to improvements in the medical care of obesity and its associated diseases. The primary aim of this project is to evaluate whether this reduction in the detrimental association of obesity with mortality rate over calendar time is supported by other data from U.S. prospective studies.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Between 1960 and 2000 (up to 40 years)
Time frame: Between 1960 and 2000 (up to 40 years)
University of Alabama at Birmingham
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06737042
Body Weight, Body Weight Changes
Bessemer, Alabama, United States
View Trial DetailsNCT06935838
Body Weight, Chronic Inflammation
Honolulu, Hawaii, United States
View Trial DetailsNCT06860776
Behavior, Body Weight
Kiel, Schleswig-Holstein, Germany
View Trial DetailsNCT07674875
Behavior, Body Weight
Antalya, Konyaalti, Turkey (Türkiye)
View Trial Details